Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News  >  Companies  >  All News

News : Companies

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

Dr. SCOTT NOREN U.S. SENATE CANDIDATE IN NEW YORK PROPOSES UNIQUE STUDENT LOAN AND OPIOID CRISIS SOLUTIONS

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/14/2018 | 05:40pm CEST

ITHACA, NY, June 14, 2018 (GLOBE NEWSWIRE) -- Dr. Scott Noren, candidate for U.S. Senate as a Democrat in NY State, has come out strong on student loan reform. He uniquely proposed a cap of student loan interest at 3% for all government issued loans but would like to see that extended to private loans as well. Dr. Noren says that "despite a 'thriving economy,' the life of many former students is burdened by overwhelming student loan debt". He adds that "the plans by some politicians to renegotiate interest rates has no teeth so to speak". The cap he proposes would save, in many cases, thousands of dollars in interest payments over the life of the loan and allow the student to pat down the principal of the loan faster. The current government student loan rates are 4.45% for Direct Subsidized and Unsubsidized Undergraduate; 6% for Direct Unsubsidized Graduate loans like for medical, dental and veterinary students, and 7% for Direct PLUS Loans (Graduate and Parents) loans. Renegotiating these rates, he says, would still be a far cry from a 3% cap overall.

Dr. Scott Noren
Dr. Scott Noren, U.S. Senate Candidate NY (D)


Regarding the opioid crisis, Dr. Noren says the 800 lb. gorilla has still not left the room. According to the CDC, at least 51% of all opioid prescriptions are written by primary care. In most states, as in New York, the regulations that were recently imposed cover acute prescribing and do not cover the prescribing practices for chronic pain management. Dr. Noren, an Oral & Maxillofacial Surgeon in Upstate New York, prescribes narcotics in small amounts nearly every day for his surgical patients. In doing so, he uses the I-Stop system where he checks recent narcotic prescriptions of his patients by other providers over the last 6 months. He found that in an alarming number of cases, there were patients being prescribed up to 270 pills a month with no end point. This was by M.D.'s, nurse practitioners and physician assistants. One patient told him after asking her doctor for an MRI referral for her painful back that she should "pray to Jesus". He feels that many patients have been condemned to pills versus other treatment modalities. He is proposing a new gatekeeper model for prescribing for chronic pain. This would be pharmacists and American Board of Medicine Certified Chronic Pain Specialists. Currently there is no ABOM Certification for this; there is no Chronic Pain Specialists that go through an extensive residency, only a 1-year certificate program and most Internists and Family Medicine physicians do not go through this. As a U.S. Senator, Dr. Noren would petition the American Board of Medicine to add this specialty. He contends the gravy train of prescribing without mandatory, not suggested parameters of care in narcotic pain prescribing dooms the U.S. to more opioid dependence and deaths. 

Dr. Noren will be spending this summer touring New York and on social media campaigning with these and other important issues, such as dental/medical practice, veterans, equal pay, living wage issues and health care system revamps as his platform. It will be an uphill battle he says to get non-Party affiliated Democrats as well as others to hear his unique approaches to making improvements in people's quality of life. His website goes into other issues that can be found at www.norenforsenate.com.

Attachment

Scott Noren
U.S. SENATE CANDIDATE, NY(D)
Dr. Noren for US Senate
E-Mail: [email protected]

© GlobeNewswire 2018
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Companies"
03:10pVELA : Wins Intelligent Trading Technology Award for Best High Performance Data Feed Handler - Software
BU
03:10pDIAMONDBACK ENERGY, INC. : Regulation FD Disclosure (form 8-K)
AQ
03:10pMANNATECH : Announces Preliminary Results of Tender Offer
BU
03:10pSENTINELONE : and Continuum Partner to Provide High-Growth MSP Market with Leading Advanced Endpoint Solution
BU
03:10pCELLERANT THERAPEUTICS, INC. : Presents Phase 2 Results Showing CLT-008 Significantly Reduces Risk of Infections in AML Patients Undergoing Standard Induction Chemotherapy
BU
03:10pMAGNETAR CAPITAL PARTNERS LP : - Form 8.3 - CME Group Inc
PR
03:10pLeerink Partners Announces Innovative Therapeutics Research Model
BU
03:10pADVANTEGO CORPORATION : Obtains $5 Million Equity Line
AC
03:10pDaina Graybosch, Ph.D. Joins Leerink Partners Equity Research Team
BU
03:09pSYMANTEC : Hosts Hackathon to Promote Lawfulness, Crime Prevention and Cyber Security Skills for Students
BU
Latest news "Companies"
Advertisement